Role of arachidonic acid in leukotriene B4-induced guinea-pig eosinophil homotypic aggregation

European Journal of Pharmacology

Volumn 384, Issue 2-3, 1999, Pages 183-190

  Teixeira, Mauro M ^a   Lindsay, Mark A ^b   Giembycz, Mark A ^b   Hellewell, Paul G ^c  

^a Depto Farmacol Inst Cie B   (Brazil)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

5 Lipoxygenase; Aggregation; Arachidonic acid; Eosinophil; Leukotriene B4; Phospholipase A2; Signal transduction

Indexed keywords

1 ETHYL 6 [[3 FLUORO 5 (3,4,5,6 TETRAHYDRO 4 METHOXY 2H PYRAN 4 YL)]PHENOXYMETHYL] 2 QUINOLONE; 5 ETHYL 2 HYDROXY 4 [6 METHYL 6 (1H TETRAZOL 5 YL)HEPTYLOXY]ACETOPHENONE; ARACHIDONIC ACID; COMPLEMENT COMPONENT C5A; LEUKOTRIENE B4; LEUKOTRIENE B4 RECEPTOR; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIPOXYGENASE INHIBITOR; MEPACRINE; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHOLIPASE A2 INHIBITOR;

ANIMAL CELL; ARACHIDONIC ACID METABOLISM; ARTICLE; CALCIUM CELL LEVEL; CELL ACTIVATION; CELL AGGREGATION; CONTROLLED STUDY; DOSE RESPONSE; EOSINOPHIL; GUINEA PIG; IN VITRO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ARACHIDONIC ACID; CALCIUM; CELL AGGREGATION; DOSE-RESPONSE RELATIONSHIP, DRUG; EOSINOPHILS; FEMALE; GUINEA PIGS; LEUKOTRIENE ANTAGONISTS; LEUKOTRIENE B4; LIPOXYGENASE INHIBITORS; MALE; PHOSPHOLIPASES A; PYRANS; QUINACRINE; QUINOLONES; TETRADECANOYLPHORBOL ACETATE; TETRAZOLES;

EID: 0033431807     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00697-4     Document Type: Article

References (33)

1. Arai T., Bhunia A.K., Chatterjee S., Bulkley G.B.M. Lactosylceramide stimulates human neutrophils to upregulate Mac-1, adhere to endothelium, and generate reactive oxygen metabolites in vitro. Circ. Res. 82:1998;540-547.
2. Badwey J.A., Curnutte J.T., Robinson J.M., Berde C.B., Karnovsky M.J., Karnovsky M.L. Effects of free fatty acids on release of superoxide and on change of shape by human neutrophils. Reversibility by albumin. J. Biol. Chem. 259:1984;7870-7877.
3. Bargatze R.F., Kurk S., Butcher E.C., Jutila M.A. Neutrophils roll on adherent neutrophils bound to cytokine-induced endothelial cells via L-selectin on the rolling cells. J. Exp. Med. 180:1994;1785-1792.
4. Bates E.J., Ferrante A., Harvey D.P., Poulos A. Polyunsaturated fatty acids increase neutrophil adherence and integrin receptor expression. J. Leukocyte Biol. 53:1993;420-426.
5. Bruijnzeel-Koomen C., Storz E., Menz G., Bruijnzeel P. Skin eosinophilia in patients with allergic and non-allergic asthma and atopic dermatitis. J. Allergy Clin. Immunol. 89:1992;52-59.
6. Capodici C., Pillinger M.H., Han G., Philips M.R., Weissmann G. Integrin-dependent homotypic adhesion of neutrophils. Arachidonic acid activates Raf-1/Mek/Erk via a 5-lipoxygenase-dependent pathway. J. Clin. Invest. 102:1998;165-175.
7. 1 integrin. J Cell. Physiol. 173:1997;361-370.
8. Djukanovic R., Roche W.R., Wilson J.W., Beasley C.R.W., Twentyman O.P., Howarth P.H., Holgate S.T. Mucosal inflammation in asthma. Am. Rev. Respir. Dis. 142:1990;434-457.
9. Giembycz M.A., Lindsay M.A. Pharmacology of the eosinophil. Pharmacol. Rev. 51:1999;213-340.
10. 4 but no peptidoleukotriene. J. Immunol. 144:1990;1880-1885.
11. 2. J. Immunol. 151:1993;5639-5652.
12. Koenderman L., Kuijpers T.W., Blom M., Tool A.T., Roos D., Verhoeven A.J. Characteristics of CR3-mediated aggregation in human eosinophils: effect of priming by platelet-activating factor. J. Allergy Clin. Immunol. 87:1991;947-954.
13. 4 formation by purified human eosinophils can be induced by arachidonic acid in the absence of calcium-ionophore A23187. Agents Actions. 26:1989;96-98.
14. Kusner E.J., Buckner C.K., Dea D.M., Dehaas C.J., Marks R.L., Krell R.D. The 5-lipoxygenase inhibitors, ZD2138 and ZM230487, are potent and selective inhibitors of several antigen-induced guinea-pig pulmonary responses. Eur. J. Pharmacol. 257:1994;285-291.
15. 4-induced eosinophil activation. J. Leukocyte Biol. 64:1998;555-562.
16. 4 activates the NADPH oxidase in eosinophils by a pertussis-toxin-sensitive mechanism that is largely independent of arachidonic mobilization. J. Immunol. 160:1998;4526-4534.
17. 4 receptor. Biochem. J. 342:1999;79-85.
18. McLaren D.J. Schistosoma Mansoni: The Parasite Surface in Relation to Host Immunity. 1980;Research Studies Press, Chichester, UK.
19. 2+-dependent protein kinase. Science. 224:1984;622-625.
20. Meurer R., Van Riper, Feeney G.W., Cunningham P., Hora D., Springer M.S., Macintyre D.E., Rosen H. Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1a, or human interleukin 8. J. Exp. Med. 178:1993;1913-1921.
21. 4 expressed on guinea-pig peritoneal eosinophils. Immunology. 77:1992;129-135.
22. 4 receptor antagonist. Eur. J. Pharmacol. 223:1992;57-64.
23. Smith R.J., Sam R.M., Justen J.M., Leach K.L., Epps D.E. Human polymorphonuclear neutrophil activation with arachidonic acid. Br. J. Pharmacol. 91:1987;641-649.
24. 2+ rise and superoxide anion generation in guinea-pig eosinophils are not related events. Br. J. Pharmacol. 187:1992;670-676.
25. Teixeira M.M., Hellewell P.G. The selectin binding polysaccharide fucoidin inhibits eosinophil recruitment in vivo. Br. J. Pharmacol. 120:1997;1059-1066.
26. Teixeira M.M., Reynia S., Robinson M., Shock A., Williams T.J., Williams F.M., Rossi A.G., Hellewell P.G. Role of CD11/CD18 in mediating cutaneous inflammation in the guinea pig. Br. J. Pharmacol. 111:1994;811-818.
27. Teixeira M.M., Williams T.J., Au B.-T., Hellewell P.G., Rossi A.G. Characterisation of eosinophil homotypic aggregation. J. Leukocyte Biol. 57:1995;226-234.
28. Teixeira M.M., Williams T.J., Hellewell P.G. Mechanisms and pharmacological modulation of eosinophil accumulation in vivo. Trends Pharmacol. Sci. 16:1995;418-423.
29. Teixeira M.M., Rossi A.G., Hellewell P.G. Adhesion mechanisms involved in C5a-induced eosinophil homotypic aggregation. J. Leukocyte Biol. 59:1996;389-396.
30. 4- and C5a-induced eosinophil homotypic aggregation in vitro and recruitment in vivo. Blood. 89:1997;4566-4573.
31. 2. J. Clin. Invest. 91:1993;2118-2125.
32. 2 in tumor necrosis factor-induced apoptosis. PNAS. 94:1997;5073-5077.
33. 4 that mediates chemotaxis. Nature. 387:1997;620-624.